|
|
Blood, 1 July 2007, Vol. 110, No. 1, pp. 74-81.
Prepublished online as a Blood First Edition Paper on March 19, 2007; DOI 10.1182/blood-2006-08-034447.
 Previous Article | Next Article 
Submitted August 2, 2006
Accepted January 23, 2007
Biology of umbilical cord blood progenitors in bone marrow niches
Mo A Dao, Michael H Creer, Jan A Nolta, and Catherine M Verfaillie*
Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, United States
Departments of Pathology and Laboratory Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States
Department of Internal Medicine, Division of Oncology, Hematopoietic Development and Malignancy Program, Washington University School of Medicine, St. Louis, MO, United States
Stamcel Instituut Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
* Corresponding author; email: catherine.verfaillie{at}med.kuleuven.be.
Within the bone marrow, hematopoietic progenitor cells (HPCs) are localized in poorly oxygenated niches where they interact with the surrounding osteoblasts (OB) through VLA4/VCAM-1 engagement, and are exposed to interleukin-6 (IL-6), stem cell factor (SCF), and chemokines such as CXCL12 (OB-factors). Umbilical cord (UC) is more highly oxygenated that the BM microenvironment. When UC-HPCs are exposed to the 2% O2 concentration found in the bone endosteum, their survival is significantly decreased. However, engagement of VLA-4 integrins on UCB-derived CD34+ cells reduced cell death in 2% O2 conditions, which was associated with an increase in phospho-Ser473 AKT and an increase in phospho-Ser9 GSK3b. Consistent with the role of GSK3b in destabilizing beta-catenin, there was more cytoplasmic beta-catenin in UC-HPCs exposed to 2% O2 on fibronectin, compared to suspension culture. UC-HPC cultured at 2% O2 with OB-factors showed an increase in nuclear beta-catenin and persistence of a small pool of CD34+38neg HPCs. CFU assays followed by surface phenotyping of the plated colonies showed improved maintenance of mixed lineage colonies with both erythroid and megakaryocytic precursors. These studies provide a biological perspective for how UC-derived HPCs adapt to the bone endosteum which is low in oxygen and densely populated by osteoblasts.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Q. Lacy, S. R. Hayman, M. A. Gertz, A. Dispenzieri, F. Buadi, S. Kumar, P. R. Greipp, J. A. Lust, S. J. Russell, D. Dingli, et al.
Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
J. Clin. Oncol.,
October 20, 2009;
27(30):
5008 - 5014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-P. Fermand
Initial Therapy for Multiple Myeloma: Role of Stem Cell Transplantation
ASCO Educational Book,
January 1, 2008;
2008(1):
375 - 379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-Y. Jang and S. J. Sharkis
A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche
Blood,
October 15, 2007;
110(8):
3056 - 3063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
